Travoprost and Gastritis - a phase IV clinical study of FDA data

Summary:

Gastritis is reported as a side effect among people who take Travoprost (travoprost), especially for people who are female, 60+ old, also take Aspirin, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Gastritis when taking Travoprost. It is created by eHealthMe based on reports of 3,311 people who have side effects when taking Travoprost from the FDA, and is updated regularly.

What is Travoprost?

Travoprost has active ingredients of travoprost. It is often used in glaucoma. eHealthMe is studying from 3,333 Travoprost users. Check the latest studies of Travoprost.

What is Gastritis?

Gastritis (inflammation of stomach) is found to be associated with 1,718 drugs and 1,917 conditions by eHealthMe. Check the latest studies of Gastritis.

On Aug, 04, 2026

3,311 people reported to have side effects when taking Travoprost.
Among them, 13 people (0.39%) have Gastritis.

Among these 13 people:

What is the gender of people who have Gastritis when taking Travoprost? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Gastritis when taking Travoprost? *

What are other drugs people take besides Travoprost? *

Aspirin: 5 people, 38.46%
Dicyclomine Hydrochloride: 3 people, 23.08%
Norvasc: 3 people, 23.08%
Metronidazole: 3 people, 23.08%
Maxzide: 3 people, 23.08%
Losartan Potassium: 3 people, 23.08%
Prochlorperazine Edisylate: 3 people, 23.08%
Bosulif: 3 people, 23.08%
Gabapentin: 3 people, 23.08%
Fluorouracil: 3 people, 23.08%

What are other side effects people have besides Gastritis? *

Pneumonia: 5 people, 38.46%
Anaemia (lack of blood): 5 people, 38.46%
Diarrhea: 5 people, 38.46%
Fatigue (feeling of tiredness): 4 people, 30.77%
Fall: 4 people, 30.77%
Dehydration (dryness resulting from the removal of water): 4 people, 30.77%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 30.77%
Inflammation: 3 people, 23.08%
Gastric Haemorrhage (bleeding stomach): 3 people, 23.08%
Infection: 3 people, 23.08%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 30.77%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 23.08%
Osteoporosis (bones weak and more likely to break): 2 people, 15.38%
Neuropathy Peripheral (surface nerve damage): 2 people, 15.38%
Multiple Myeloma (cancer of the plasma cells): 2 people, 15.38%
Immune System Disorder: 2 people, 15.38%
Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 15.38%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Travoprost and have Gastritis?

- Check whether Gastritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Travoprost:

Travoprost (3,333 reports)

Gastritis treatments and more:

Gastritis (55,650 reports)

Browse all side effects of Travoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastritis:

Gastritis (1,718 drugs)

Browse all the conditions that are associated with Gastritis:

Gastritis (1,917 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on travoprost (the active ingredients of Travoprost) and Travoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.